Predictive factors and influence of intravesical therapy for recurrence of non-muscle invasive bladder cancer

被引:0
作者
Garcia-Rodriguez, Jorge [1 ,2 ]
Fernandez Gomez, Jesus Maria [1 ]
Gonzalez Alvarez, Roberto Carlos [1 ]
Jalon Monzon, Antonio [1 ]
Regadera Sejas, Javier [1 ]
Martin Benito, Jose Luis [1 ]
机构
[1] Hosp Univ Cent Asturias, Oviedo 33010, Spain
[2] Oncol Hosp Univ Cent Asturias, Oviedo, Spain
来源
SALUD I CIENCIA | 2009年 / 17卷 / 03期
关键词
superficial bladder cancer; recurrence; intravesical instillation; TRANSITIONAL-CELL CARCINOMA; CALMETTE-GUERIN THERAPY; RISK-FACTORS; T1; PROGRESSION; TA; SURVIVAL; TUMORS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: We assessed the predictive factors for recurrence of non-muscle invasive bladder cancer, and the effect of intravesical therapy. Material and Methods: We examined 419 bladder neoplasms. Univariate and multivariate analyses were done on 24 variables of these bladder neoplasms, and various treatments were assessed. Results: There were significant differences in the disease-free interval before recurrence, which was shorter in tumors recurring within 12 months, in multiple tumors (3 or more tumors), and bladder dome cancers. Also, there were statistically significant differences when two homogeneous groups of surgeons were studied. Intravesical instillation therapy increased time to relapse as an independent factor. A significant delay in recurrence was demonstrated when high BCG doses and maintenance treatment were used. Conclusions: Independent factors associated with shorter disease-free interval before recurrence were the following: cancer relapse within the first year, multiple tumors, surgical procedure, non-use of bladder washing, treatment with low BCG doses, and induction intravesical therapy vs. maintenance treatment. Intravesical instillations using high BCG doses and BCG maintenance treatment, increased the period of time before relapse.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 25 条
[1]   Superficial bladder tumours: analysis of prognostic factors and construction of a predictive index [J].
Ali-El-Dein, B ;
Sarhan, O ;
Hinev, A ;
Ibrahiem, EHI ;
Nabeeh, A ;
Ghoneim, MA .
BJU INTERNATIONAL, 2003, 92 (04) :393-399
[2]   Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette-Guerin [J].
Andius, P ;
Damm, O ;
Holmäng, S .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2004, 38 (04) :285-290
[3]  
[Anonymous], 2002, TNM CLASSIFICATION M
[4]   Long-term results of intravesical bacillus Calmette-Guerin therapy for stage T1 superficial bladder cancer [J].
Brake, M ;
Loertzer, H ;
Horsch, R ;
Keller, H .
UROLOGY, 2000, 55 (05) :673-678
[5]   Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies [J].
Brausi, M ;
Collette, L ;
Kurth, K ;
van der Meijden, AP ;
Oosterlinck, W ;
Witjes, JA ;
Newling, D ;
Bouffioux, C ;
Sylvester, RJ .
EUROPEAN UROLOGY, 2002, 41 (05) :523-530
[6]   Chemo-prevention in superficial bladder cancer using mitomycin C: a survey of the practice patterns of British urologists [J].
Clarke, NS ;
Basu, S ;
Prescott, S ;
Puri, R .
BJU INTERNATIONAL, 2006, 97 (04) :716-719
[7]   Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer [J].
Fujii, Y ;
Fukui, I ;
Kihara, K ;
Tsujii, T ;
Kageyama, Y ;
Oshima, H .
EUROPEAN UROLOGY, 1999, 36 (04) :309-313
[8]  
GOMEZ JF, 2008, EUR UROL, V53, P992
[9]   SUPERFICIAL BLADDER-CANCER - PROGRESSION AND RECURRENCE [J].
HENEY, NM ;
AHMED, S ;
FLANAGAN, MJ ;
FRABLE, W ;
CORDER, MP ;
HAFERMANN, MD ;
HAWKINS, IR .
JOURNAL OF UROLOGY, 1983, 130 (06) :1083-1086
[10]   Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome [J].
Herr, HW .
JOURNAL OF UROLOGY, 2000, 163 (01) :60-61